All News

Watch Dr. Rupesh Kotecha, from Miami Cancer Institute, Baptist Health South Florida, discuss the treatment of brain metastases during the CURE Educated Patient® Breast Cancer Summit at MBCC.

Patients with HR+/HER2- early breast cancer treated with the CDK4/6 inhibitor plus endocrine therapy in the phase 3 NATALEE trial had a reduced risk for the cancer to recur.

Two-year follow-up data showed that Rybrevant was promising in a difficult-to-treat subtype of non-small cell lung cancer.

After being diagnosed with Lynch syndrome, a hereditary cancer syndrome, I saw my imperfect situation as an opportunity to educate and connect with others.

From the San Diego Padres’ coach missing Opening Day for colon cancer surgery to WWE star Alexa Bliss sharing her skin cancer experience and warning people against tanning beds, here’s what’s happening in the oncology space this week.

Watch Dr. Ana C. Sandoval Leon, from Miami Cancer Institute, Baptist Health South Florida, discuss HER2-positive metastatic disease during the CURE Educated Patient® Breast Cancer Summit at MBCC.

In this Educated Patient® webinar, CURE® spoke with experts from Allegheny Health Network about addressing disparities in diversity, equity and inclusion in cancer care.

Cancer survivors shared why they disclosed — or didn’t disclose — their cancer diagnosis to their employers.

After being diagnosed with cancer and taking a look at all the stuff I accumulated, I began to think about my priorities in life.

The current testing rate for BRCA 1/2 mutations is currently 68% in HER2-negative early breast cancer, but eligible patients could receive better care if tested.

Watch Dr. Naomi Dempsey, from Miami Cancer Institute, discuss the management of HER2-positive, early-stage disease during the CURE Educated Patient® Breast Cancer Summit at MBCC.

My cancer diagnosis — and the emotional effects that came with it — made me who I am today.

The Food and Drug Administration approved Keytruda for adult and pediatric patients with previously treated unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors.

Antibody drug conjugates, which are used to treat various types of cancer, can cause eye issues, though they are easily treated if caught early, one expert said.

The way I see it, double the cancer diagnoses means double the victory.

The phase 3 ARASTEP trial will investigate Nubeqa plus androgen-deprivation therapy in certain patients with hormone-sensitive prostate cancer.

Watch Dr. Patrick Borgen, from Maimonides Medical Center, discuss the de-escalation of surgery during the CURE Educated Patient® Breast Cancer Summit at MBCC.

Twenty-five years ago, I was diagnosed with ovarian cancer, which sparked fears of leaving my loved ones behind.

A marathon runner who was diagnosed with metastatic melanoma learned that what she enjoyed doing before cancer could help her regain her energy and identity during and after treatment.

I’m reflecting on the distant past — a time before my cancer diagnoses.

Skipping radiation therapy for breast cancer may not affect 10-year survival, but one radiation oncologist suggests patient noncompliance with endocrine therapy is the real reason for reduced benefits.

Watch Dr. Joseph Panoff, from Miami Cancer Institute, Baptist Health South Florida, discuss radiation therapy in early stage disease during the CURE Educated Patient® Breast Cancer Summit at MBCC.

Patients with ovarian cancer who utilized palliative care tended to have fewer hospital readmissions than those who did not, according to a recent study.

Patients with advanced melanoma who followed the Mediterranean diet tended to have improved responses to immunotherapy treatment, recent research showed.

I am amazed at how a song drenched in hope emerges out of the fog when I need it most during cancer.

The temporary tattoos that guided the radiation for my cancer treatment were not beautiful, artistic or cool — they were more than that.

Watch Dr. Susan Domchek, Dr. Debu Tripathy and Dr. Jennifer Gass answer questions about precision medicine during the CURE Educated Patient® Breast Cancer Summit at MBCC.

Watch Dr. Debu Tripathy, from The University of Texas MD Anderson Cancer Center, discuss circulating tumor DNA during the CURE Educated Patient® Breast Cancer Summit at MBCC.

I’m looking back and sharing the lessons learned from 10 years of cancer survivorship.

Watch Dr. Susan Domchek, from Penn Medicine, discuss genetic testing during the CURE Educated Patient® Breast Cancer Summit at MBCC.